
News|Articles|May 23, 2024
Don’t underestimate the "small stuff"
Author(s)Eurofins BioPharma Product Testing
Learn about the importance of considering human factors testing beyond the initial validation phase. Through two case studies, it illustrates how seemingly minor product changes can trigger regulatory scrutiny. The message is clear: proactive testing and expert guidance are essential to navigate regulatory requirements effectively.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
FDA Deploys Agentic AI Capabilities for Agency Staff
3
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
4
PharmTech Weekly News Roundup – Week of December 1, 2025
5
